[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"library-module6":3,"library-matrix-all":121},{"module9":4,"module8":25,"module7":34,"module6":43,"module5":63,"module4":73,"module3":96,"module2":102,"intro":112},{"id":5,"type":6,"title":7,"subtitle":8,"description":9,"imageUrl":10,"videoLink":10,"videoCover":10,"buttonText":10,"buttonLink":10,"sort":11,"status":12,"features":13},9,"module9","RenSuper Membership Plans","\u003Cp>\u003Cbr>\u003C\u002Fp>","\u003Cp>Flexible membership plans for antibody data, library access, and advanced antibody design tools.\u003C\u002Fp>","",0,1,[14,19],{"id":15,"moduleId":5,"title":16,"subtitle":17,"description":18,"imageUrl":10,"sort":12},210,"Basic Membership","Free","\u003Cp>Ideal for individual researchers looking to explore our target and PCC libraries with essential data insights.\u003C\u002Fp>",{"id":20,"moduleId":5,"title":21,"subtitle":22,"description":23,"imageUrl":10,"sort":24},211,"Professional Membership","Contact Sales","\u003Cp>Designed for professionals who require full data access, antibody design tools, and collaborative workflow features.\u003C\u002Fp>",2,{"id":26,"type":27,"title":10,"subtitle":28,"description":8,"imageUrl":10,"videoLink":29,"videoCover":30,"buttonText":10,"buttonLink":10,"sort":11,"status":12,"features":31},8,"module8","\u003Cp>See How RenSuper\u003C\u002Fp>\u003Cp>Antibody Design Platform Works\u003C\u002Fp>","https:\u002F\u002Fbiocytogen-no2.oss-cn-beijing.aliyuncs.com\u002Fdc1c924b48cf42f7a1fe911fa9b71d53.mp4","https:\u002F\u002Fbiocytogen-no2.oss-cn-beijing.aliyuncs.com\u002Ff887d3b7ea74409b9e9d94f428d79a59.png",[32],{"id":33,"moduleId":26,"title":10,"subtitle":10,"description":8,"imageUrl":10,"sort":12},184,{"id":35,"type":36,"title":37,"subtitle":8,"description":38,"imageUrl":39,"videoLink":10,"videoCover":10,"buttonText":10,"buttonLink":10,"sort":11,"status":12,"features":40},7,"module7","All Binder Types","\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0)\">Biocytogen's comprehensive, fully human antibody portfolio spans diverse binder formats. We support a wide range of discovery needs—from high-affinity monoclonals and plug-and-play bispecific formats to compact VHH molecules with deep tissue penetration, as well as antibodies targeting hard-to-drug GPCRs and other challenging targets.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>","https:\u002F\u002Fbiocytogen-no2.oss-cn-beijing.aliyuncs.com\u002F20260127\u002FAll-Binder-Types_1769482852242.png",[41],{"id":42,"moduleId":35,"title":10,"subtitle":10,"description":8,"imageUrl":10,"sort":12},149,{"id":44,"type":45,"title":46,"subtitle":8,"description":47,"imageUrl":48,"videoLink":10,"videoCover":10,"buttonText":10,"buttonLink":10,"sort":11,"status":12,"features":49},6,"module6","Full Target Library","\u003Cp>Built on the proprietary RenMice\u003Csup>®\u003C\u002Fsup> platform, Biocytogen's antibody library offers access to 1,000+ druggable targets and over one million experimentally validated, fully human antibody sequences, providing partners with a highly reliable and efficient source of discovery-ready molecules.\u003C\u002Fp>\u003Cp>This comprehensive library supports the development of diverse therapeutic modalities—including bispecific antibodies, multispecific antibodies, ADCs, VHHs, oligonucleotide-based therapies, and cell therapies—with broad applications across oncology, autoimmune, metabolic, and neurological diseases.\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>","https:\u002F\u002Fbiocytogen-no2.oss-cn-beijing.aliyuncs.com\u002F42563e1cb94c41d19a05e5610f549a09.png",[50,54,58],{"id":51,"moduleId":44,"title":52,"subtitle":53,"description":8,"imageUrl":10,"sort":12},157,"1000+","Druggable Targets",{"id":55,"moduleId":44,"title":56,"subtitle":57,"description":10,"imageUrl":10,"sort":24},158,"1M+","Fully Human Antibody Sequences",{"id":59,"moduleId":44,"title":60,"subtitle":61,"description":10,"imageUrl":10,"sort":62},159,"280+","Partnerships",3,{"id":64,"type":65,"title":66,"subtitle":67,"description":68,"imageUrl":69,"videoLink":10,"videoCover":10,"buttonText":10,"buttonLink":10,"sort":11,"status":12,"features":70},5,"module5","questions or inquiries?","\u003Ch3>Contact Us\u003C\u002Fh3>","\u003Cp>\u003Cspan style=\"color: rgb(81, 81, 108);background-color: rgb(255, 255, 255)\">We work closely with leading biotech and pharmaceutical companies around the world to advance cutting-edge drug discovery programs. Share your inquiry here—we'll be in touch soon.\u003C\u002Fspan>\u003C\u002Fp>","https:\u002F\u002Fbiocytogen-no2.oss-cn-beijing.aliyuncs.com\u002F20251204\u002Fbox4-logo1_1764815193433.png",[71],{"id":72,"moduleId":64,"title":10,"subtitle":10,"description":8,"imageUrl":10,"sort":12},88,{"id":74,"type":75,"title":76,"subtitle":77,"description":8,"imageUrl":10,"videoLink":29,"videoCover":78,"buttonText":10,"buttonLink":10,"sort":11,"status":12,"features":79},4,"module4","Antibody Design","\u003Cp>How to Design Antibodies with RenSuper Workstation\u003C\u002Fp>","https:\u002F\u002Fbiocytogen-no2.oss-cn-beijing.aliyuncs.com\u002F25de66bd08e04118b3e39243a1060b00.jpg",[80,84,88,92],{"id":81,"moduleId":74,"title":10,"subtitle":82,"description":8,"imageUrl":83,"sort":12},186,"\u002Fantibody-design","https:\u002F\u002Fbiocytogen-no2.oss-cn-beijing.aliyuncs.com\u002F20260114\u002FFrame 1160449460 (1)_1768399355761.png",{"id":85,"moduleId":74,"title":10,"subtitle":10,"description":86,"imageUrl":87,"sort":24},187,"\u003Cp>RenSuper supports drag-and-assemble design of flexible antibody formats, including monoclonal, bispecific, multispecific, VHH, and TCR constructs.\u003C\u002Fp>","https:\u002F\u002Fbiocytogen-no2.oss-cn-beijing.aliyuncs.com\u002F20251204\u002Fbox3-icon1_1764814985892.png",{"id":89,"moduleId":74,"title":10,"subtitle":10,"description":90,"imageUrl":91,"sort":62},188,"\u003Cp>Choose from a million-scale library of fully human binder sequences covering 1,000+ targets to build your next antibody therapeutic.\u003C\u002Fp>","https:\u002F\u002Fbiocytogen-no2.oss-cn-beijing.aliyuncs.com\u002F20251204\u002Fbox3-icon2_1764815008529.png",{"id":93,"moduleId":74,"title":10,"subtitle":10,"description":94,"imageUrl":95,"sort":74},189,"\u003Cp>Built-in affinity and functionality analysis ensures the selection of high-confidence designs.\u003C\u002Fp>","https:\u002F\u002Fbiocytogen-no2.oss-cn-beijing.aliyuncs.com\u002F20251204\u002Fbox3-icon3_1764815025540.png",{"id":62,"type":97,"title":10,"subtitle":98,"description":8,"imageUrl":10,"videoLink":10,"videoCover":10,"buttonText":10,"buttonLink":10,"sort":11,"status":12,"features":99},"module3","\u003Cp>\u003Cstrong>RenSuper Antibody Design Workstation\u003C\u002Fstrong> is a \u003C\u002Fp>\u003Cp>digitalized and automated platform enabling \u003C\u002Fp>\u003Cp>multi-format, fully human antibody \u003Cimg src=\"https:\u002F\u002Fbiocytogen-no2.oss-cn-beijing.aliyuncs.com\u002Ff1c99bb9d22d42b993798744be6dd916.png\" alt=\"Frame 15323.png\" data-href=\"https:\u002F\u002Fbiocytogen-no2.oss-cn-beijing.aliyuncs.com\u002Ff1c99bb9d22d42b993798744be6dd916.png\" style=\"width: 43.00px;height: 43.00px;\"> discovery.\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>Powered by an advanced \u003Cimg src=\"https:\u002F\u002Fbiocytogen-no2.oss-cn-beijing.aliyuncs.com\u002Feae5f6f83a14471893b05971fb959eca.png\" alt=\"Frame 15323 (1).png\" data-href=\"https:\u002F\u002Fbiocytogen-no2.oss-cn-beijing.aliyuncs.com\u002Feae5f6f83a14471893b05971fb959eca.png\"> AI model trained on 100M+ fully human \u003C\u002Fp>\u003Cp>antibody sequences, the RenSuper Workstation reduces antibody design \u003C\u002Fp>\u003Cp>timelines from years to hours—eliminating the need for repetitive animal \u003C\u002Fp>\u003Cp>immunization and CRO outsourcing.\u003C\u002Fp>",[100],{"id":101,"moduleId":62,"title":10,"subtitle":10,"description":8,"imageUrl":10,"sort":12},213,{"id":24,"type":103,"title":104,"subtitle":105,"description":106,"imageUrl":10,"videoLink":10,"videoCover":10,"buttonText":107,"buttonLink":10,"sort":11,"status":12,"features":108},"module2","Antibody-based Assets","\u003Cp>Preclinical Candidate Portfolio\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>","\u003Cp>Biocytogen's RenMab\u003Csup>®\u003C\u002Fsup>, RenLite\u003Csup>®\u003C\u002Fsup>, and RenNano\u003Csup>®\u003C\u002Fsup> platforms power the generation of fully human monoclonal, bispecific, and hu-VHH antibodies with strong therapeutic potential.\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>Through these platforms, we offer a diverse and expanding portfolio of preclinical candidate (PCC) molecules to meet the evolving drug development needs of our partners.\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>","Search Products",[109],{"id":110,"moduleId":24,"title":111,"subtitle":10,"description":8,"imageUrl":10,"sort":12},185,"标题1",{"id":12,"type":113,"title":10,"subtitle":114,"description":115,"imageUrl":116,"videoLink":10,"videoCover":10,"buttonText":10,"buttonLink":117,"sort":11,"status":12,"features":118},"intro","\u003Cp>Powered by our proprietary RenMice\u003Csup>®\u003C\u002Fsup> platforms, Biocytogen provides an off-the-shelf library of 1M+ fully human antibody sequences spanning 1,000+ targets—ready for rapid drug discovery\u003C\u002Fp>","\u003Cp>SEARCH FOR THE RENSUPER BIOLOGICS LIBRARY\u003C\u002Fp>","https:\u002F\u002Fbiocytogen-no2.oss-cn-beijing.aliyuncs.com\u002F20251209\u002Fbanner-title_1765243432546.png","http:\u002F\u002Fadmin-dev.biocytogen.com.cn\u002Fconfig\u002Findex-module",[119],{"id":120,"moduleId":12,"title":10,"subtitle":10,"description":8,"imageUrl":10,"sort":12},172,{"miceTypeDict":122,"matrix":136,"initialPlatforms":-1},[123,128,132],{"id":124,"label":125,"value":126,"dictType":127},3149,"RenNano","RN","target_mice_type",{"id":129,"label":130,"value":131,"dictType":127},3150,"RenLite","RL",{"id":133,"label":134,"value":135,"dictType":127},3151,"RenMab","RM",{"code":11,"msg":10,"data":137},{"platforms":138,"groups":139,"total":241,"pageNo":12,"pageSize":242},[135,131,126],[140],{"therapeuticArea":141,"targets":142},"all",[143,149,155,159,165,169,175,181,187,191,195,199,203,207,211,215,221,225,231,237],{"target":144,"commonName":144,"targetDisplay":144,"officialName":144,"therapeuticArea":141,"platformMatched":145,"platformOngoing":147},"KIT",{"RM":146,"RL":146,"RN":146},true,{"RM":148,"RL":148,"RN":148},false,{"target":150,"commonName":150,"targetDisplay":151,"officialName":152,"therapeuticArea":141,"platformMatched":153,"platformOngoing":154},"APRIL","APRIL(TNFSF13)","TNFSF13",{"RM":146,"RL":146,"RN":146},{"RM":146,"RL":148,"RN":148},{"target":156,"commonName":156,"targetDisplay":156,"officialName":156,"therapeuticArea":141,"platformMatched":157,"platformOngoing":158},"C3",{"RM":146,"RL":146,"RN":146},{"RM":146,"RL":148,"RN":148},{"target":160,"commonName":160,"targetDisplay":161,"officialName":162,"therapeuticArea":141,"platformMatched":163,"platformOngoing":164},"CD142","CD142(F3)","F3",{"RM":146,"RL":146,"RN":146},{"RM":146,"RL":148,"RN":148},{"target":166,"commonName":166,"targetDisplay":166,"officialName":166,"therapeuticArea":141,"platformMatched":167,"platformOngoing":168},"CD38",{"RM":146,"RL":146,"RN":146},{"RM":146,"RL":148,"RN":148},{"target":170,"commonName":170,"targetDisplay":171,"officialName":172,"therapeuticArea":141,"platformMatched":173,"platformOngoing":174},"CD40L","CD40L(CD40LG)","CD40LG",{"RM":146,"RL":146,"RN":146},{"RM":146,"RL":148,"RN":148},{"target":176,"commonName":176,"targetDisplay":177,"officialName":178,"therapeuticArea":141,"platformMatched":179,"platformOngoing":180},"CD71","CD71(TFRC)","TFRC",{"RM":146,"RL":146,"RN":146},{"RM":146,"RL":148,"RN":148},{"target":182,"commonName":182,"targetDisplay":183,"officialName":184,"therapeuticArea":141,"platformMatched":185,"platformOngoing":186},"CD98","CD98(SLC3A2)","SLC3A2",{"RM":146,"RL":146,"RN":146},{"RM":146,"RL":148,"RN":148},{"target":188,"commonName":188,"targetDisplay":188,"officialName":188,"therapeuticArea":141,"platformMatched":189,"platformOngoing":190},"CDH17",{"RM":146,"RL":146,"RN":146},{"RM":146,"RL":148,"RN":148},{"target":192,"commonName":192,"targetDisplay":192,"officialName":192,"therapeuticArea":141,"platformMatched":193,"platformOngoing":194},"CEACAM5",{"RM":146,"RL":146,"RN":146},{"RM":146,"RL":148,"RN":148},{"target":196,"commonName":196,"targetDisplay":196,"officialName":196,"therapeuticArea":141,"platformMatched":197,"platformOngoing":198},"CSF1R",{"RM":146,"RL":146,"RN":146},{"RM":146,"RL":148,"RN":148},{"target":200,"commonName":200,"targetDisplay":200,"officialName":200,"therapeuticArea":141,"platformMatched":201,"platformOngoing":202},"EGFR",{"RM":146,"RL":146,"RN":146},{"RM":146,"RL":148,"RN":148},{"target":204,"commonName":204,"targetDisplay":204,"officialName":204,"therapeuticArea":141,"platformMatched":205,"platformOngoing":206},"FGFR4",{"RM":146,"RL":146,"RN":146},{"RM":146,"RL":148,"RN":148},{"target":208,"commonName":208,"targetDisplay":208,"officialName":208,"therapeuticArea":141,"platformMatched":209,"platformOngoing":210},"FOLR1",{"RM":146,"RL":146,"RN":146},{"RM":146,"RL":148,"RN":148},{"target":212,"commonName":212,"targetDisplay":212,"officialName":212,"therapeuticArea":141,"platformMatched":213,"platformOngoing":214},"GDF15",{"RM":146,"RL":146,"RN":146},{"RM":146,"RL":148,"RN":148},{"target":216,"commonName":216,"targetDisplay":217,"officialName":218,"therapeuticArea":141,"platformMatched":219,"platformOngoing":220},"HER3","HER3(ERBB3)","ERBB3",{"RM":146,"RL":146,"RN":146},{"RM":146,"RL":148,"RN":148},{"target":222,"commonName":222,"targetDisplay":222,"officialName":222,"therapeuticArea":141,"platformMatched":223,"platformOngoing":224},"IGF1R",{"RM":148,"RL":146,"RN":146},{"RM":148,"RL":148,"RN":148},{"target":226,"commonName":226,"targetDisplay":227,"officialName":228,"therapeuticArea":141,"platformMatched":229,"platformOngoing":230},"IL36R","IL36R(IL1RL2)","IL1RL2",{"RM":146,"RL":146,"RN":146},{"RM":146,"RL":148,"RN":148},{"target":232,"commonName":232,"targetDisplay":233,"officialName":234,"therapeuticArea":141,"platformMatched":235,"platformOngoing":236},"IL4RA","IL4RA(IL4R)","IL4R",{"RM":146,"RL":146,"RN":146},{"RM":146,"RL":148,"RN":148},{"target":238,"commonName":238,"targetDisplay":238,"officialName":238,"therapeuticArea":141,"platformMatched":239,"platformOngoing":240},"IL6",{"RM":146,"RL":146,"RN":146},{"RM":146,"RL":148,"RN":148},1146,20]